Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05639881 · ClinicalTrials.gov registry record · NA
Enhancing Immune Health Randomized Controlled Trial
A NA study of Mental Disorder, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05639881: Recruiting NA study of Mental Disorder, sponsored by University of Illinois at Chicago.
NCT05639881 is a NA study of Mental Disorder that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 100 participants, below the 320-participant average among 21 other Mental Disorder trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05639881, a NA study of Mental Disorder, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests a psychosocial intervention to improve immune health literacy and behaviors among adults with mental illnesses.
Primary Outcome
The Immune Status Questionnaire (ISQ) measures self-reported immune status. The questionnaire consists of 7 items measuring indicators of immune health including headache, muscle and joint pain, cough, and sudden high fever. Respondents rate each item using a 5-point Likert scale ranging from "never" to "always or almost always." Responses are coded 0-4 and summed for a total score potentially ranging from 0 to 28 with higher scores indicating a poorer immune status.
Conditions Studied
Interventions
- BEHAVIORAL Enhancing Your Immune Health
Study Locations (1)
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What NCT05639881 shows while recruiting
NCT05639881 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 320-participant average among 21 other Mental Disorder trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Mental Disorder appearing as the primary indexed condition, and to 1 intervention - of which Enhancing Your Immune Health is the first listed.
NCT05639881 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05639881 about?
NCT05639881 is a clinical study titled "Enhancing Immune Health Randomized Controlled Trial". This study tests a psychosocial intervention to improve immune health literacy and behaviors among adults with mental illnesses.
What is the current status of trial NCT05639881?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-05-01. Estimated completion is 2026-02-28.
What conditions does trial NCT05639881 study?
This clinical trial studies the following conditions: Mental Disorder.
What interventions are being tested in trial NCT05639881?
The interventions under investigation include: Enhancing Your Immune Health (BEHAVIORAL).
Who is sponsoring clinical trial NCT05639881?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05639881 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05639881's enrollment target sits among peer trials
100 13th of 21 higher than 9 of 21 other Mental Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mental Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT for HIV-Positive Men
RECRUITING · NA
-
Healthy ReStart Intervention to Improve Health and Functioning
RECRUITING · NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
-
Transdiagnostic Behavior Therapy Vs TAU for Adjustment Disorder Following Traumatic Event Exposure
RECRUITING · NA
-
Brain Stimulation to the Hippocampus in Schizophrenia
RECRUITING · NA
-
FCT Study: Reducing the Need for Out-of-Home Placements
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI